Abstract：【Objective】 To compare the efficacy and safety of sublingual specific immunotherapy(SLIT) and subcutaneous specific immunotherapy(SCIT) in children with allergic rhinitis.【Methods】 A total of 102 children with dust mite-induced allergic rhinitis admitted to our hospital from January 2022 to May 2024 were selected as research subjects, and divided into an observation group(treated with SLIT) and a control group(treated with SCIT) using the random number table method, with 51 cases in each group. The total nasal symptom score(TNSS) and visual analogue scale(VAS) score of the two groups before treatment and 1 year after treatment were compared, as well as the total medication score(TMS), total treatment cost, incidence of adverse reactions and treatment dropout rate of the two groups after 1 year of treatment.【Results】 One year after treatment, the TNSS and VAS scores of both groups were lower than those before treatment, with statistically significant differences(P<0.05), but there were no statistically significant differences in TNSS and VAS scores between the two groups(P>0.05). One year after treatment, the TMS of the observation group was higher than that of the control group, while the total treatment cost, total incidence of adverse reactions and total treatment dropout rate of the observation group were lower than those of the control group, with statistically significant differences(P<0.05).【Conclusion】 SLIT and SCIT have comparable efficacy in improving the symptoms of allergic rhinitis in children, but SLIT has higher safety, better compliance and lower cost, making it more suitable as the preferred clinical desensitization regimen. It provides practical evidence for standardized desensitization treatment of allergic rhinitis in children.
王剑, 唐美玲, 徐孝华. 舌下与皮下特异性免疫治疗在儿童变应性鼻炎治疗中的疗效与安全性比较[J]. 医学临床研究, 2026, 43(1): 95-98.
WANG Jian, TANG Meiling, XU Xiaohua. Efficacy and Safety Comparison of Sublingual and Subcutaneous Specific Immunotherapy in Children with Allergic Rhinitis. JOURNAL OF CLINICAL RESEARCH, 2026, 43(1): 95-98.
2026, Vol. 43 
